J066--NEW - GenMark Svc

Special Notice of Intent to Award a Sole Source Procurement

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to GenMark Diagnostics Inc. for service and maintenance needed to maintain performance of the HCVg Molecular Diagnostic testing on the Government Owned (2) Analyzer Module Systems (GenMark XT-8) located in the Molecular Laboratory of Pathology & Laboratory Medicine Service at STVHCS.

Period of Performance for one year: Plus (4) one-year options.

The proposed sole source procurement will be made by an open market pricing agreement with GenMark Diagnostics Inc.

GenMark Diagnostics Inc. is the only manufacturer of the eSensor assay cartridges, including the eSensor HCVg Direct Test Kit (RUO) Panel Assay (Part# MT008102).

GenMark Diagnostics is the sole supplier and distributor in the US for the Assays mentioned above.

This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 10 days from the publication of this notice, a contract will be issued to GenMark Diagnostics Inc.

The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1 Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

Notice: the POC for this notice does not have a Federal Business Opportunities registration account. Do NOT respond in the Interested Vendors List . The POC does not have any visibility to the Interested Vendors List tab within the notice. Interested firms must respond directly to the POC email address listed in the notice for consideration.